Skip to content
Recovery & Performance PeptidesRecovery research and practical context
Source comparison

BPC-157 Studied Intestinal Permeability: Comparison of Research Models

TNBS-Induced Colitis Chemical irritant causing transmural inflammation 10 μg/kg daily for 7–14 days Mucosal ulceration index, inflammatory cytokine levels 60% reduction in ulceration, 70% reduction in TNF-α and IL-6 Most relevant model for Crohn's-like inflamm

This comparison does not assign a generated winner or score.

  • TNBS-Induced Colitis
  • Chemical irritant causing transmural inflammation
  • 10 μg/kg daily for 7–14 days
  • Mucosal ulceration index, inflammatory cytokine levels
  • 60% reduction in ulceration, 70% reduction in TNF-α and IL-6
  • Most relevant model for Crohn's-like inflammatory damage. Demonstrates both structural and biochemical barrier restoration
  • NSAID-Induced Enteropathy
  • COX enzyme inhibition disrupting prostaglandin synthesis
  • 10–100 μg/kg before or after NSAID exposure
  • Intestinal lesion counts, mucosal blood flow
  • 80% reduction in lesion formation
  • Strong evidence for preventive and reparative effects. Particularly relevant for patients on long-term NSAID therapy
  • Ischemia-Reperfusion Injury
  • Blood flow interruption followed by restoration
  • 10 μg/kg administered at reperfusion
  • Bacterial translocation to lymph nodes, vascular density
  • 65% reduction in bacterial translocation, restored mucosal vascularisation within 72 hours
  • Functional barrier measure (bacterial translocation) is the gold standard. Shows BPC-157 improves actual permeability, not just tissue appearance
More references

Related material